# Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process

> **NCT03605303** · NA · TERMINATED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 3 (actual)

## Conditions studied

- Refractive Error Correction

## Interventions

- **DEVICE:** Test/Control
- **DEVICE:** Control/Test

## Key facts

- **NCT ID:** NCT03605303
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-03
- **Primary completion:** 2018-07-05
- **Final completion:** 2018-07-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** This study was terminated due to the released lenses not representing what will be made commercially available and thus the objectives could not be met
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03605303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03605303, "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03605303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*